Prostanoid receptors: Structures, properties, and functions

Physiological Reviews

Volumn 79, Issue 4, 1999, Pages 1193-1226

  Narumiya, Shuh ^a   Sugimoto, Yukihiko ^b   Ushikubi, Fumitaka ^b  

^a KYOTO UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE; PROSTANOID RECEPTOR; THROMBOXANE A2;

CELL STIMULATION; CENTRAL NERVOUS SYSTEM; GENE EXPRESSION; GENE STRUCTURE; HOMEOSTASIS; IMMUNITY; INFLAMMATION; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION;

EID: 0032823306     PISSN: 00319333     EISSN: None     Source Type: Journal    
DOI: 10.1152/physrev.1999.79.4.1193     Document Type: Review

References (254)

1. ABE, T., K. TAKEUCHI, N. TAKAHASHI, E. TSUTSUMI, Y. TANIYAMA, AND K. ABE. Rat kidney thromboxane receptor: molecular cloning, signal transduction, and intrarenal expression localization. J. Clin. Invest. 96: 657-664, 1995.
2. ABRAMOVITZ, M., Y. BOIE, T. NGUYEN, T. H. RUSHMORE, M. A. BAYNE, K. M. METTERS, D. M. SLIPETS, AND R. GRYGORCZYK. Cloning and expression of a cDNA for the human prostanoid FP receptor. J. Biol. Chem. 269: 2632-2636, 1994.
3. 3 prostanoid receptor. FEBS Lett. 338: 170-174, 1994.
4. 2 receptor density and aggregation responses. Circulation 91: 2742-2747, 1995.
5. 2 in rats. Pharmacol. Biochem. Behav. 46: 383-389, 1993.
6. 2. Biochem. Biophys. Res. Commun. 197: 263-270, 1993.
7. ANDERSEN, N. H., T. L. EGGERMAN, L. A. HARKER, C. H. WILSON, AND B. DE. On the multiplicity of platelet prostaglandin receptors. I. Evaluation of competitive antagonism by aggregometry. Prostaglandins 19: 711-735, 1980.
8. 4 receptor gene. J. Biol. Chem. 271: 29569-29575, 1996.
9. 2 hyperthermia Brain Res. 748: 245-249, 1997.
10. ARMSTRONG, R. A., R. A. LAWRENCE, R. J. JONES, N. H. WILSON, AND A. COLLIER. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors. Br. J. Pharmacol. 97: 657-668, 1989.
11. 3 receptor. Mol. Pharmacol. 51: 61-68, 1997.
12. 3 receptor is an essential determinant of ligand selectivity. J. Biol. Chem. 272: 13475-13478, 1997.
13. 2 subtype. J. Biol. Chem. 269: 11873-11877, 1994.
14. BATEMAN, A., A. SINGH, K. THOMAS, AND S. SOLOMON. The immune-hypothalamic-pituitary-adrenal axis. Endocr. Rev. 10: 92-112, 1989.
15. 1 receptor gene. Eur. J. Biochem. 231: 809-814, 1995.
16. BERKENBOSCH, F., J. VAN OERS, A. DEL REY, F. TILDERS, AND H. BESEDOVSKY. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 238: 524-526, 1987.
17. BESEDOVSKY, H. A., A. DEL REY, E. SORKIN, AND C. A. DINARELLO. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233: 652-654, 1986.
18. BITO, L. Z. Accumulation and apparent active transport of prostaglandins by some rabbit tissues in vitro. J. Physiol. (Lond.) 221: 371-387, 1972.
19. BLEY, K. R., J. C. HUNTER, R. M. EGLEN, AND J. A. M. SMITH. The role of IP prostanoid receptors in inflammatory pain. Trends Pharmacol. Sci. 19: 141-147, 1998.
20. BOIE, Y., T. H. RUSHMORE, A. DARMON-GOODWIN, R. GRYGORCZYK, D. M. SLIPETS, K. M. METTERS, AND M. ABRAMOVITZ. Cloning and expression of a cDNA for the human prostanoid IP receptor. J. Biol. Chem. 269: 12173-12178, 1994.
21. BOIE, Y., N. SAWYER, D. M. SLIPETZ, K. M. METTERS, AND M. ABRAMOVITZ. Molecular cloning and characterization of the human prostanoid DP receptor. J. Biol. Chem. 270: 18910-18916, 1995.
22. 2 prostanoid receptor subtypes. Eur. J. Pharmacol. 340: 227-241, 1997.
23. 2. Nature 390: 622-625, 1997.
24. BOUVIER, M., S. MOFFETT, T. P. LOISEL, B. MOUILLAC, T. HEBERT, AND P. CHIDIAC. Palmitoylation of G-protein-coupled receptors: a dynamic modification with functional consequences. Biochem. Soc. Trans. 23: 116-120, 1995.
25. 3 receptor. Kidney Int. 43: 1372-1378, 1993.
26. BREYER, M. D., L. DAVIS, H. R. JACOBSON, AND R. M. BREYER. Differential localization of prostaglandin E receptor subtypes in human kidney. Am. J. Physiol. 270 (Renal Physiol. 39): F912-F918, 1996.
27. 2 receptor. J. Biol. Chem. 269: 6163-6169, 1994.
28. BRILLIANT, M. F., R. W. WILLIAMS, C. J. CONTI, J. M. ANGEL, R. J. OAKEY, AND B. C. HOLDENER. Mouse chromosome 7. Mamm. Genome 5, Suppl.: S104-S123, 1994.
29. 2α concentrations on ion transport across human jejunum mucosa. Gastroenterology 78: 32-42, 1980.
30. BURKE, S. E., A. M. LEFER, K. C. NICOLAOU, G. M. SMITH, AND J. B. SMITH. Responsiveness of platelets and coronary arteries from different species to synthetic thromboxane and prostaglandin endoperoxide analogues. Br. J. Pharmacol. 78: 287-292, 1983.
31. 1, and insulin on cyclic AMP levels in the rat epididymal fat pad in vitro. Ann. NY Acad. Sci. 139: 849-859, 1967.
32. CAO, C., K. MATSUMURA, K. YAMAGATA, AND Y. WATANABE. Induction by lipopolysaccharide of cyclooxygenase-2 mRNA in rat brain: its possible role in the febrile response. Brain Res. 697: 187-196, 1995.
33. CHAN, W. Y., I. BEREZIN, E. E. DANIEL, K. C. RUSSEL, AND V. J. HRUBY. Effects of inactivation of oxytocin receptor and inhibition of prostaglandin synthesis on uterine oxytocin receptor and gap junction formation and labor in the rat. Can. J. Physiol. Pharmacol. 69: 1262-1267, 1991.
34. 3 subtype. Biochem. J. 322: 597-601, 1997.
35. CHANG, C.-S., M. NEGISHI, N. NISHIGAKI, AND A. ICHIKAWA. Characterization of functional interaction of carboxylic acid group of agonists and arginine of the seventh transmembrane domains of four prostaglandin E receptor subtypes. Prostaglandins 54: 437-446, 1997.
36. 2 receptor in insect cells. Arch. Biochem. Biophys. 334: 9-17, 1996.
37. 2 receptor in ligand binding. Arch. Biochem. Biophys. 352: 207-213, 1998.
38. CLARK, W. G., AND J. M. LIPTON. Hyperthermic effect of prostacyclin injected into the third cerebral ventricle of the cat. Brain Res. Bull. 4: 15-16, 1979.
39. 1α. Prostaglandins 16: 259-264, 1978.
40. COCEANI, F., AND P. M. OLLEY. The control of cardiovascular shunts in the fetal and perinatal period. Can J. Physiol. Pharmacol. 66: 1129-1134, 1988.
41. 2. Eur. J. Pharmacol. 238: 391-394, 1993.
42. COLEMAN, R. A., L. FENIUK, AND I. KENNEDY. A study of the prostanoid receptors mediating bronchoconstriction in the anaesthetized guinea-pig and dog (Abstract). Br. J. Pharmacol. 74: 913P-914P, 1981.
43. COLEMAN, R. A., S. P. GRIX, S. A. HEAD, J. B. LOUTTIT, A. MALLETT, AND R. L. G. SHELDRICK. A novel inhibitory receptor in piglet saphenous vein. Prostaglandins 47: 151-168, 1994.
44. COLEMAN, R. A., I. KENNEDY, P. P. A. HUMPHREY, K. BUNCE, AND P. LUMLEY. Prostanoids and their receptors. In: Comprehensive Medicinal Chemistry. Membranes and Receptors, edited by J. C. Emmett. Oxford, UK: Pergamon, 1990, vol. 3, p. 643-714.
45. 2-sensitive (EP) receptors (Abstract). Br. J. Pharmacol. 91: 323P, 1987.
46. COLEMAN, R. A., AND R. L. G. SHELDRICK. Prostanoid-induced contraction of human bronchial smooth muscle is mediated by TP-receptors. Br. J. Pharmacol. 96: 688-692, 1989.
47. D'ANGELO, D. D., J. J. EUBANK, M. G. DAVIS, AND G. W. DORN II. Mutagenic analysis of platelet thromboxane receptor cysteines: roles in ligand binding and receptor effector coupling. J. Biol. Chem. 271: 6233-6240, 1996.
48. DAVATELIS, G., S. D. WOLPE, B. SHERRY, J. M. DAYER, R. CHICHEPORTICHE, AND A. CERAMI. Macrophage inflammatory protein-1: a prostaglandin independent endogenous pyrogen. Science 243: 1066-1068, 1989.
49. DAVIES, P., P. J. BAILEY, M. M. GOLDENBERG, AND A. W. FORDHUCHINSON. The role of arachidonic acid oxygenation products in pain and inflammation. Annu. Rev. Immunol. 2: 335-357, 1984.
50. DAVISSON, M. T., P. A. LALLEY, J. PETERS, D. P. DOOLITTLE, A. L. HILLYARD, AND A. G. SEARLE. Report of the comparative committee for human, mouse and other rodents. Cytogenet. Cell Genet. 58: 1152-1189, 1991.
51. DINCHUCK, J. E., B. D. CAR, R. J. FOCHT, J. J. JOHNSTON, B. D. JAFFEE, M. B. COVINGTON, N. R. CONTEL, V. M. ENG, R. J. COLLINS, P. M. CZERNIAK, S. A. GORRY, AND J. M. TRZASKOS. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 378: 406-409, 1995.
52. DOHLMAN, H. G., J. THORNER, M. G. CARON, AND R. J. LEFKOWITZ. Model systems for the study of seven-transmembrane-segment receptors. Annu. Rev. Biochem. 60: 653-688, 1991.
53. DONG, Y. J., AND R. L. JONES. Effects of prostaglandin and thromboxane analogues on bullock and dog iris sphincter preparations. Br. J. Pharmacol. 76: 149-155, 1982.
54. 2 receptor subtypes: a radioligand binding study of human platelets. J. Clin. Invest. 84: 1883-1891, 1989.
55. 2 receptor number and affinity in human platelet membranes. J. Biol. Chem. 265: 4240-4246, 1990.
56. DORN, G. W., II, M. W. BECKER, AND M. G. DAVIS. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle. J. Biol. Chem. 267: 24897-24905, 1992.
57. DORN, G. W., II, M. G. DAVIS, AND D. D. D'ANGELO. Gene expression during phorbol ester-induced differentiation of cultured human megakaryoblastic cells. Am. J. Physiol. 266 (Cell Physiol. 35): C1231-C1239, 1994.
58. DORN, G. W., II, M. G. DAVIS, AND D. D. D'ANGELO. Structural determinant for agonist binding affinity to thromboxane/prostaglandin endoperoxide (TP) receptors: analysis of chimeric rat/ human receptors. J. Biol. Chem. 272: 12399-12405, 1997.
59. DUNCAN, A. M. V., L. L. ANDERSON, C. D. FUNK, M. ABRAMOVITZ, AND M. ADAM. Chromosomal localization of the human prostanoids receptor gene family. Genomics 25: 740-742, 1995.
60. 4 subtypes regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells. Proc. Natl. Acad. Sci. USA 93: 10978-10983, 1996.
61. 4 receptor. J. Exp. Med. 180: 253-260, 1994.
62. 4 receptor gene and related pseudogenes. Genomics 35: 182-188, 1996.
63. 1 subtype. J. Biol. Chem. 268: 26767-26772, 1993.
64. 2 receptor allows discrimination between agonist and antagonist binding sites. Mol. Pharmacol. 44: 934-939, 1993.
65. 2 activation. Blood 81: 994-1000, 1993.
66. GARDINER, P. J., AND H. O. J. COLLIER. Specific receptors for prostaglandins in airways. Prostaglandins 19: 819-841, 1980.
67. GILES, H., P. LEFF, M. L. BOLOFO, M. G. KELLY, AND A. D. ROBERTSON. The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist. Br. J. Pharmacol. 96: 291-300, 1989.
68. GOLLMAN, H. M., AND T. A. RUDY. Comparative pyrogenic potency of endogenous prostanoids and of prostanoid-mimetics injected into the anterior hypothalamic/preoptic region of the cat. Brain Res. 449: 281-293, 1988.
69. GOUREAU, O., Z. TANFIN, S. MARC, AND S. HARBON. Diverse prostaglandin receptors activate distinct signal transduction pathways in rat myometrium. Am. J. Physiol. 263 (Cell Physiol. 32): C257-C265, 1992.
70. 2α from the ovine corpus luteum. Endocrinology 136: 3430-3436, 1995.
71. HABIB, A., R. VEZZA, C. CREMINON, J. MACLOUF, AND G. A. FITZGERALD. Rapid, agonist-dependent phosphorylation in vivo of human thromboxane receptor isoforms. J. Biol. Chem. 272: 7191-7200, 1997.
72. HAKEDA, Y., Y. NAKATANI, M. HIRAMATSU, N. KURIHARA, M. TSUNOI, E. IKEDA, AND M. KUMEGAWA. Inductive effects of prostaglandins on alkaline phosphatase in osteoblastic cells, clone MC3T3-E1. J. Biochem. 97: 97-104, 1985.
73. HALUSHKA, P. V., D. E. MAIS, P. R. MAYEUX, AND T. A. MORINELLI. Thromboxane, prostaglandin and leukotriene receptors. Annu. Rev. Pharmacol. Toxicol. 10: 213-239, 1989.
74. 3 subtype different in agonist-independent constitutive activity. J. Biol. Chem. 271: 1857-1860, 1996.
75. HASUMOTO, K., Y. SUGIMOTO, M. GOTOH, E. SEGI, A. YAMASAKI, M. YAMAGUCHI, H. HONDA, H. HIRAI, M. NEGISHI, A. KAKIZUKA, AND A. ICHIKAWA. Characterization of the mouse prostaglandin F receptor gene: a transgenic mouse study of a regulatory region that controls its expression in the stomach and kidney but not in the ovary. Genes Cells 2: 571-580, 1997.
76. 2α receptor associates with luteal cell apoptosis in the ovary of the pseudopregnant mouse. J. Reprod. Fertil. 109: 45-51, 1997.
77. HAUSDORFF, W. P., M. G. CARON, AND R. J. LEFKOWITZ. Turning off the signal: desensitization of β-adrenergic receptor function. FASEB J. 4: 2881-2889, 1990.
78. 2. FASEB J. 5: 2575-2581, 1991.
79. 2 receptor. Nature 349: 617-620, 1991.
80. HIRATA, M., A. KAKIZUKA, M. AIZAWA, F. USHIKUBI, AND S. NARUMIYA. Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene. Proc. Natl. Acad. Sci. USA 91: 11192-11196, 1994.
81. 2 receptor in a dominantly inherited bleeding disorder. J. Clin. Invest. 94: 1662-1667, 1994.
82. 60 to Leu mutation. J. Clin. Invest. 97: 949-956, 1996.
83. 2. Proc. Natl. Acad. Sci. USA. In press.
84. 2 subtype. J. Biol. Chem. 268: 7759-7762, 1993.
85. HONDA, Z., M. NAKAMURA, I. MIKI, M. MINAMI, T. WATANABE, Y. SEYAMA, H. OKADO, H. TOH, K. ITO, T. MIYAMOTO, AND T. SHIMIZU. Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature 349: 342-346, 1991.
86. 2α. Physiol. Rev. 56: 595-651, 1976.
87. 3 subtype in insect cells. Biochem. J. 307: 493-498, 1995.
88. HUANG, P. L., Z. HUANG, H. MASHIMO, K. D. BLOCH, M. A. MOSKOWITZ, J. A. BEVAN, AND M. C. FISHMAN. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242, 1995.
89. HUSSLEIN, P., A. R. FUCHS, AND F. FUCHS. Oxytocin and the initiation of human parturition. Am. J. Obstet. Gynecol. 141: 688-693, 1981.
90. 3 subtype with different C-terminal tail coupling to both stimulation and inhibition of adenylate cyclase. Eur. J. Biochem. 217: 313-318, 1993.
91. ISHIKAWA, T., Y. TAMAI, J. M. ROCHELLE, M. HIRATA, T. NAMBA, Y. SUGIMOTO, A. ICHIKAWA, S. NARUMIYA, M. TAKETO, AND M. F. SELDIN. Mapping of the genes encoding mouse prostaglandin D, E, and F and prostacyclin receptors. Genomics 32: 285-288, 1996.
92. q in cDNA-transfected Chinese hamster ovary cells. Biochem. Biophys. Res. Commun. 200: 756-762, 1994.
93. 2. Bone 8: 171-178, 1987.
94. 3 isoforms. Br. J. Pharmacol. 121: 317-323, 1997.
95. JONES, R. L., V. PEESAPATI, AND N. H. WILSON. Antagonism of the thromboxane-sensitive contractile systems of the rabbit aorta, dog saphenous vein anad guinea-pig trachea. Br. J. Pharmacol. 76: 423-438, 1982.
96. KAJIKAWA, N., K. NOGIMORI, T. MURATA, S. NISHIO, AND S. UCHIYAMA. Specific binding of the new stable epoprostenol analogue beraprost sodium to prostacyclin receptors on human and rat platelets. Arzneim. Forsch. 39: 495-499, 1989.
97. 2 receptors. Life Sci. 28: 2553-2560, 1981.
98. KANDASAMY, S. B., AND B. A. WILLIAMS. Prostacyclin-induced hyperthermia: implication of a protein mediator. Neuropharmacology 21: 1065-1072, 1982.
99. KATSUURA, G., A. ARIMURA, K. KOVES, AND P. E. GOTTSCHALL. Involvement of organum vasculosum of lamina terminalis and preoptic area in interleukin 1β-induced ACTH release. Am. J. Physiol. 258 (Endocrinol. Metab. 21): E163-E171, 1990.
100. 4 prostaglandin E receptors in macrophage-like cell line, J774.1. Biochem. Biophys. Res. Commun. 251: 727-731, 1998.
101. 2 subtype: cloning, expression, and Northern blot analysis. FEBS Lett. 372: 151-156, 1995.
102. KATSUYAMA, M., Y. SUGIMOTO, K. MORIMOTO, K. HASUMOTO, M. FUKUMOTO, M. NEGISHI, AND A. ICHIKAWA. Distinct cellular localization of the messenger ribonucleic acid for prostaglandin E receptor subtypes in the mouse uterus during pseudopregnancy. Endocrinology 138: 344-350, 1997.
103. KATSUYAMA, M., Y. SUGIMOTO, T. NAMBA, A. IRIE, M. NEGISHI, S. NARUMIYA, AND A. ICHIKAWA. Cloning and expression of a cDNA for the human prostacyclin receptor. FEBS Lett. 344: 74-78, 1994.
104. 2: tissue-specific initiation of transcription in the macrophage and the uterus. Biochem. J. 330: 1115-1121, 1998.
105. 2 prostaglandin receptor confers responsiveness to prostacyclin analogs. Mol. Pharmacol. 54: 584-590, 1998.
106. 2 receptor. Nature Med. 5: 217-220, 1999.
107. KENNEDY, I., R. A. COLEMAN, P. P. A. HUMPHREY, G. P. LEVY, AND P. LUMLEY. Studies on the characterization of prostanoid receptors: a proposed classification. Prostaglandins 24: 667-689, 1982.
108. 2 receptor. J. Biol. Chem. 269: 29914-29919, 1994.
109. KIRIYAMA, M., F. USHIKUBI, T. KOBAYASHI, M. HIRATA, Y. SUGIMOTO, AND S. NARUMIYA. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br. J. Pharmacol. 122: 217-224, 1997.
110. 2 receptor. Prostaglandins 48: 31-41, 1994.
111. KLEIN, D. C., AND L. G. RAISZ. Prostglandins: stimulation of bone resorption in tissue culture. Endocrinology 86: 1436-1440, 1970.
112. KLUGER, M. J. Fever role of pyrogens and cryogens. Physiol. Rev. 71: 93-127, 1991.
113. 2 receptors. J. Biol. Chem. 268: 26011-26017, 1993.
114. KOBAYASHI, T., M. KIRIYAMA, T. HIRATA, M. HIRATA, F. USHIKUBI, AND S. NARUMIYA. Identification of domains conferring ligand binding specificity to the prostanoid receptor: studies on chimeric prostacyclin/prostaglandin D receptors. J. Biol. Chem. 272: 15154-15160, 1997.
115. 3 receptor subtype gene (PTGER3). Genomics 40: 425-434, 1997.
116. 2 receptors in the central and peripheral effects of prostacyclin on circulatory system in rats. Biomed. Biochim. Acta 43, Suppl.: S199-S202, 1984.
117. KUEHL, F. A., AND J. L. HUMES. Direct evidence for a prostaglandin receptor and its application to prostaglandin measurement. Proc. Natl. Acad. Sci. USA 69: 480-484, 1972.
118. KUSHNER, I. The phenomenon of the acute phase response. Ann. NY Acad. Sci. 389: 39-48, 1982.
119. 2α receptor. FEBS Lett. 355: 317-325, 1994.
120. 2 generation after activation of rat and human mast cells with anti-IgE. J. Immunol. 129: 1627-1631, 1982.
121. LEWIS, R. B., AND J. D. SCHULMAN. Influence of acetylsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labour. Lancet 24: 1159-1161, 1973.
122. 2 gene expression in the mouse uterus coincides with differentiation of the luminal epithelium for implantation. Endocrinology 138: 4599-4606, 1997.
123. LIM, H., B. C. PARIA, S. K. DAS, J. E. DINCHUCK, R. LANGENBACH, J. M. TRZASKOS, AND S. K. DEY. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 91: 197-208, 1997.
124. LIN, J. H., AND M. T. LIN. Inhibition of nitric oxide or cyclooxygenase pathways in organum vasculosum laminae terminalis attenuates interleukin-1β fever in rabbits. Neurosci. Lett. 208: 155-158, 1996.
125. LIN, J. H., AND M. T. LIN. Nitric oxide synthase-cyclo-oxygenase pathways in organum vasculosum laminae terminalis: possible role in pyrogenic fever in rabbits. Br. J. Pharmacol. 118: 179-185, 1996.
126. 2 receptor: evidence for N-glycosylation. Eur. J. Pharmacol. 227: 267-274, 1992.
127. MALMBERG, A. B., AND T. L. YAKSH. Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science 257: 1276-1279, 1992.
128. 2 sensitivity of the organum vasculosum lamina terminalis region and preoptic area in rat brain slices. J. Physiol. (Lond.) 454: 197-212, 1992.
129. 2 receptor expression in human erythroleukemia cells. Am. J. Physiol. 265 (Endocrinol. Metab. 28): E928-E934, 1993.
130. 2-sensitive, sleep-promoting zone defined in the ventral surface of the rostral basal forebrain. Proc. Natl. Acad. Sci. USA 91: 11998-12002, 1994.
131. 2 binding sites in rat brain using quantitative autoradiography. Brain Res. 581: 292-298, 1992.
132. 3H]iloprost Neuroscience 65: 493-503, 1995.
133. 2 binding sites in the anterior wall of the 3rd ventricle: a possible site of its hyperthermic action. Brain Res. 533: 147-151, 1990.
134. McCONKEY, D. J., S. ORRENIUS, AND M. JONDAL. Cellular signalling in programed cell death (apoptosis). Immunol. Today 11: 120-121, 1990.
135. McCRACKEN, J. A., AND W. SCHRAMM. Prostaglandins and corpus luteum regression. In: Prostaglandins: Biology and Chemistry of Prostaglandins and Related Eicosanoids, edited by P. B. Curtis-Prior. London: Churchill Livingstone, 1988, p. 425-462.
136. 1 as a modulator for temperature regulation in the central nervous system of the cat (Abstract). J. Physiol. (Lond.) 207: 76P-77P, 1970.
137. MITCHELL, D., H. P. LABURN, K. E. COOPER, R. F. HELLON, W. I. CRANSTON, AND Y. TOWNSEND. Is prostaglandin E the neural mediator of the febrile response? The case against a proven obligatory role. Yale J. Biol. Med. 59: 159-168, 1986.
138. 2. J. Immunol 155: 4437-4444, 1995.
139. 3 subtype of putative serotonergic neurons in the dorsal raphe nucleus of the rat. Naunyn-Schmiedebergs Arch. Pharmacol. 353: 377-381, 1996.
140. 4 subtype: differential regulation in monocytoid and lymphoid lineage cells by phorbol ester. J. Mol. Med. 74: 333-336, 1996.
141. MORIMOTO, A., N. MURAKAMI, T. NAKAMORI, Y. SAKATA, AND T. WATANABE. Possible involvement of prostaglandin E in developement of ACTH response in rats induced by human recombinant interleukin 1. J. Physiol. (Lond.) 411: 245-256, 1989.
142. MORIMOTO, A., N. MURAKAMI, T. NAKAMORI, AND T. WATANABE. Multiple control of fever production in the central nervous system of rabbits. J. Physiol. (Lond.) 397: 269-280, 1988.
143. MORIMOTO, K., Y. SUGIMOTO, M. KATSUYAMA, H. OIDA, K. TSUBOI, K. K. ISHI, Y. KONOSHITA, M. NEGISHI, T. CHIBA, S. NARUMIYA, AND A. ICHIKAWA. Cellular localization of mRNAs for prostaglandin E receptor subtypes in mouse gastrointestinal tract. Am. J. Physiol. 272 (Gastrointest. Liver Physiol. 35): G681-G687, 1997.
144. 2 receptor agonist. J. Pharmacol. Exp. Ther. 251: 557-562, 1989.
145. 2 receptor: molecular cloning, expression, and functional characterization. Naunyn-Schmiedebergs Arch. Pharmacol. 357: 10-16, 1998.
146. MURATA, T., F. USHIKUBI, T. MATSUOKA, M. HIRATA, A. YAMASAKI, Y. SUGIMOTO, A. ICHIKAWA, Y. AZE, T. TANAKA, N. YOSHIDA, A. UENO, S. OH-ISHI, AND S. NARUMIYA. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 388: 678-682, 1997.
147. MURDOCH, W. J., T. R. HANSEN, AND L. A. McPHERSON. Role of eicosanoids in vertebrate ovulation. Prostaglandins 46: 85-115, 1993.
148. NAKAGAWA, O., I. TANAKA, T. USUI, M. HARADA, Y. SASAKI, H. ITOH, T. YOSHIMASA, T. NAMBA, S. NARUMIYA, AND K. NAKAO. Molecular cloning of human prostacyclin receptor cDNA and its gene expression in cardiovascular system. Circulation 90: 1643-1647, 1994.
149. 2 receptor in cultured human erythroleukemia cells and its induction by 12-O-tetradecanoylphorbol-13-acetate. Biochem. Biophys. Res. Commun. 158: 958-965, 1989.
150. NAKAMURA, M., Z. HONDA, T. IZUMI, C. SAKANAKA, H. MUTOH, M. MINAMI, H. BITO, Y. SEYAMA, T. MATSUMOTO, M. NOMA, AND T. SHIMIZU. Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. J. Biol. Chem. 266: 20400-20405, 1991.
151. NAMBA, T., H. OIDA, Y. SUGIMOTO, A. KAKIZUKA, M. NEGISHI, A. ICHIKAWA, AND S. NARUMIYA. cDNA cloning of a mouse prostacyclin receptor: multiple signalling pathways and expression in thymic medulla. J. Biol. Chem. 269: 9986-9992, 1994.
152. 2 receptor: cDNA cloning, expression and Northern blot analysis. Biochem. Biophys. Res. Commun. 184: 1187-1203, 1992.
153. 3 determines G-protein specificity. Nature 365: 166-170, 1993.
154. NARUMIYA, S., M. HIRATA, T. NAMBA, Y. HAYASHI, F. USHIKUBI, Y. SUGIMOTO, M. NEGISHI, AND A. ICHIKAWA. Structure and function of prostanoid receptors. J. Lipid Mediators 6: 155-161, 1993.
155. NARUMIYA, S., M. OKUMA, AND F. USHIKUBI. Binding of a radioiodinated 13 azapinane thromboxane antagonist to platelets: correlation with antiaggregatory activity in different species. Br. J. Pharmacol. 88: 323-331, 1986.
156. s activity. FEBS Lett. 386: 165-168, 1996.
157. s through interaction of α-carboxylic acid of agonist and arginine residue of seventh transmembrane domain. J. Biol. Chem. 270: 16122-16127, 1995.
158. i and to phosphoinositide metabolism in a pertussis toxin-insensitive manner. J. Biol. Chem. 264: 3916-3923, 1989.
159. o. J. Biol. Chem. 268: 26067-26070, 1993.
160. 3 subtype. J. Biol. Chem. 268: 9517-9521, 1993.
161. 4 triggers remodelling of the cardiovascular system at birth. Nature 390: 78-81, 1997.
162. 4 subtype. FEBS Lett. 364: 339-341, 1995.
163. NISHIMORI, K., L. J. YOUNG, Q. GUO, Z. WANG, T. R. INSEL, AND M. M. MATZUK. Oxytocin is required for nursing but is not essential for parturition or reproductive behavior. Proc. Natl. Acad. Sci. USA 93: 11699-11704, 1996.
164. 2 receptor gene. J. Biol. Chem. 268: 25253-25259, 1993.
165. 2 and thrombin receptors in human platelets. Proc. Natl. Acad. Sci. USA 91: 504-508, 1994.
166. OGAWA, Y., I. TANAKA, M. INOUE, Y. YOSHITAKE, N. ISSE, O. NAKAGAWA, T. USUI, H. ITOH, T. YOSHIMASA, S. NARUMIYA, AND K. NAKAO. Structural organization and chromosomal assignment of the human prostacyclin receptor gene. Genomics 27: 142-148, 1995.
167. OGLETREE, M. L., AND G. T. ALLEN. Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea-pig smooth muscles. J. Pharmacol. Exp. Ther. 260: 789-794, 1992.
168. OIDA, H., M. HIRATA, Y. SUGIMOTO, F. USHIKUBI, H. OHISHI, N. MIZUNO, A. ICHIKAWA, AND S. NARUMIYA. Expression of messenger RNA for the prostaglandin D receptor in the leptomeninges of the mouse brain. FEBS Lett. 417: 53-56, 1997.
169. OIDA, H., T. NAMBA, Y. SUGIMOTO, F. USHIKUBI, H. OHISHI, A. ICHIKAWA, AND S. NARUMIYA. In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs. Br. J. Pharmacol. 116: 2828-2837, 1995.
170. 2 produces the first preovulatory surge of gonadotropins. Endocrinology 111: 1031-1037, 1982.
171. 3 receptors. Brain Res. 663: 287-292, 1994.
172. 2-induced hyperthermia. Am. J. Physiol. 267 (Regulatory Integrative Comp. Physiol. 36): R289-R294, 1994.
173. 1 subtype. J. Biol. Chem. 271: 31255-31261, 1996.
174. 2 receptors. Biochim. Biophys. Acta 1221: 83-88, 1994.
175. PARROTT, R. F., AND S. V. VELLUCCI. Effects of centrally administered prostaglandin EP receptor agonists on febrile and adrenocortical responses in the prepubertal pig. Brain Res. Bull. 41: 97-103, 1996.
176. PEREZ, A. G., AND W. L. SMITH. Apical-basolateral membrane asymmetry in canine cortical collecting tubule cells. J. Clin. Invest. 74: 63-74, 1984.
177. PHIPPS, R. P., S. H. STEIN, AND R. L. ROPER. A new view of prostaglandin E regulation of the immune response. Immunol. Today 12: 349-352, 1991.
178. PICKLES, V. R. The myometrial actions of six prostaglandins: consideration of a receptor hypothesis. In: Nobel Symposium. Prostaglandins, edited by S. Bergström and B. Samuelsson. Stockholm: Almquist & Wicksell, 1967, vol. 2, p. 79-83.
179. PIERCE, K. L., T. J. BAILEY, P. B. HOYER, D. W. GIL, D. F. WOODWARD, AND J. W. REGAN. Cloning of a carboxyl-terminal isoform of the prostanoid FP receptor. J. Biol. Chem. 272: 883-887, 1997.
180. POLL, C., S. GRIX, AND R. A. COLEMAN. Effect of SC-19220 on neurotransmission in the guinea-pig ileum (Abstract). Br. J. Pharmacol. 97: 412P, 1989.
181. 2 blocks inflammation, hyperalgesia and interleukin 6 production in vivo. J. Exp. Med. 184: 883-891, 1996.
182. 2α receptor in ovine corpora lutea. Eur. J. Biochem. 41: 103-107, 1974.
183. RAO, C. V. Receptors for prostaglandins and gonadotrophins in the cell membranes of bovine corpora lutea. Prostaglandins 4: 567-576, 1973.
184. 2 receptor. J. Biol. Chem. 269: 19256-19261, 1994.
185. 3 receptors: evidence of three variants with differing carboxyl termini. Br. J. Pharmacol. 112: 377-385, 1994.
186. 2 subtype. Mol. Pharmacol. 46: 213-220, 1994.
187. REIMERS, J. I., U. BJERRE, T. MANDRUP-POULSEN, AND J. NERUP. Interleukin-1β induces diabetes and fever in normal rats by nitric oxide via induction of different nitric oxide synthases. Cytokine 6: 512-520, 1994.
188. 2α receptor expression in cultured human granulosaluteal cells. Endocrinology 138: 191-195, 1997.
189. ROTHWELL, N. J. Central activation of thermogenesis by prostaglandins: dependence on CRF. Horm. Metab. Res. 22: 616-618, 1990.
190. 2α receptor. J. Biol. Chem. 269: 3881-3886, 1994.
191. 4 subtype of prostaglandin E receptor in osteoclast formation by proinflammatory cytokines and lipopolysaccharide. J. Bone Miner. Res. In press.
192. 2 subtype. Biochem. Biophys. Res. Commun. 200: 1329-1333, 1994.
193. SANTORO, M. G., B. M. JAFFE, AND D. J. SIMMONS. Bone resorption in vitro and in vivo in PGE-treated mice. Proc. Soc. Exp. Biol. Med. 156: 373-377, 1977.
194. SAPER, C. B., AND C. D. BREDER. The neurologic basis of fever. N. Engl. J. Med. 330: 1880-1886, 1994.
195. SAPOLSKY, R. C., C. RIVIER, G. YAMAMOTO, P. PLOTSKY, AND W. VALE. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 238: 522-524, 1987.
196. SASAKI, Y., T. USUI, I. TANAKA, O. NAKAGAWA, T. SANDO, T. TAKAHASHI, T. NAMBA, S. NARUMIYA, AND K. NAKAO. Cloning and expression of a cDNA for rat prostacyclin receptor. Biochim. Biophys. Acta 1224: 601-605, 1994.
197. SAVARSE, T. M., AND C. M. FRASER. In vitro mutagenesis and the search for structure-function relationships among G-protein-coupled receptors. Biochem. J. 283: 1-19, 1992.
198. 2 activates fever-producing autonomic pathways. J. Neurosci. 16: 6246-6254, 1996.
199. 2. Proc. Natl. Acd. Sci. USA 95: 7754-7759, 1998.
200. SCHAAF, T. K., AND H. J. HESS. Synthesis and biological activity of carboxyl-terminus modified prostaglandin analogues. J. Med. Chem. 22: 1340-1346, 1979.
201. 4-deficeint mice. Biochem. Biophys. Res. Commun. 246: 7-12, 1998.
202. 2 during lipopolysaccharide-induced fever in guinea pigs. Brain Res. Bull. 39: 391-399, 1996.
203. q family. J. Biol. Chem. 266: 9309-9313, 1991.
204. SIREN, A. Central cardiovascular and thermal effects of prostacyclin in rats. Prostaglandins 22: 945-956, 1981.
205. SIRKO, S., I. BISHAI, AND F. COCEANI. Prostaglandin formation in the hypothalamus in vivo: effect of pyrogens. Am. J. Physiol. 256 (Regulatory Integrative Comp. Physiol. 25): R616-R624, 1989.
206. SKINNER, K. A., AND J. R. G. CHALLIS. Changes in the synthesis and metabolism of prostaglandins by human fetal membranes and decidua at labor. Am. J. Obstet. Gynecol. 151: 519-523, 1985.
207. SMITH, G. C. The pharmacology of the ductus arteriosus. Pharmacol. Rev. 50: 35-58, 1998.
208. SMITH, G. C., R. A. COLEMAN, AND J. C. McGRATH. Characterization of dilator prostanoid receptors in the fetal rabbit ductus arteriosus. J. Phramacol. Exp. Ther. 271: 390-394, 1994.
209. 1 administration. J. Pediatr. 97: 866-867, 1980.
210. SONNENBURG, W. K., AND W. L. SMITH. Regulation of cyclic AMP metabolism in rabbit cortical collecting tubule cells by prostaglandins. J. Biol. Chem. 263: 6155-6160, 1988.
211. STITT, J. T. Evidence for the involvement of the organum vasculosum laminae terminalis in the febrile response of rabbits and rats. J. Physiol. (Lond.) 368: 501-511, 1985.
212. STITT, J. T. Prostaglandin E as the neural mediator of the febrile response. Yale J. Biol. Med. 59: 137-149, 1986.
213. 1 within the hypothalamus of the rat. J. Physiol. (Lond.) 432: 99-110, 1991.
214. SUGA, M., K. TANAKA, K. NATSUI, T. USUI, I. TANAKA, M. FUKUSHIMA, C. SHIGENO, J. KONISHI, S. NARUMIYA, A. ICHIKAWA, AND K. NAKAO. Prostaglandin E receptor subtypes in mouse osteoblastic cell line. Endocrinology 137: 1698-1705, 1996.
215. SUGIMOTO, Y., K. HASUMOTO, T. NAMBA, A. IRIE, M. KATSUYAMA, M. NEGISHI, A. KAKIZUKA, S. NARUMIYA, AND A. ICHIKAWA. Cloning and expression of a cDNA for mouse prostaglandin F receptor. J. Biol. Chem. 269: 1356-1360, 1994.
216. 3 subtype. J. Biol. Chem. 267: 6463-6466, 1992.
217. SUGIMOTO, Y., T. NAMBA, R. SHIGEMOTO, M. NEGISHI, A. ICHIKAWA, AND S. NARUMIYA. Distinct cellular localization of mRNAs for three subtypes of prostaglandin E receptor in kidney. Am. J. Physiol. 266 (Renal Physiol. 35): F823-F828, 1994.
218. i proteins. J. Biol. Chem. 268: 2712-2718, 1993.
219. 3 in the mouse nervous system. Neuroscience 62: 919-928, 1994.
220. SUGIMOTO, Y., A. YAMASAKI, E. SEGI, K. TSUBOI, Y. AZE, T. NISHIMURA, H. OIDA, N. YOSHIDA, T. TANAKA, M. KATSUYAMA, K. HASUMOTO, T. MURATA, M. HIRATA, F. USHIKUBI, M. NEGISHI, A. ICHIKAWA, AND S. NARUMIYA. Failure of parturition in mice lacking the prostaglandin F receptor. Science 277: 681-684, 1997.
221. 4-knockout mice (Abstract). J. Bone Miner. Res. 14, Suppl. In press.
222. TAI, H., C. MIYAURA, C. C. PILBEAM, T. TAMURA, Y. OHSUGI, Y. KOSHIHARA, N. KUBODERA, H. KAWAGUCHI, L. G. RAISZ, AND T. SUDA. Transcriptional induction of cyclooxygenase-2 in osteoblasts is involved in interleukin-6-induced osteoclast formation. Endocrinology 138: 2372-2379, 1997.
223. 2 analogues in human platelets: discrimination of two binding sites linked to distinct effector systems. J. Biol. Chem. 265: 6836-6844, 1990.
224. TAKAHASHI, N., K. TAKEUCHI, A. SUGAWARA, Y. TANIYAMA, T. KATO, C. S. WILCOX, K. ABE, AND S. ITO. Structure and transcriptional function of the 5′-flanking region of rat thromboxane receptor gene. Biochem. Biophys. Res. Commun. 244: 489-493, 1998.
225. 3. Genomics 19: 585-588, 1994.
226. 3 subtype. Biochem. Biophys. Res. Commun. 194: 885-891, 1993.
227. TAM, F. S. F., K. CHAN, J.-P. BOURREAU, AND R. L. JONES. The mechanism of enhancement and inhibition of field stimulation responses of guinea-pig vas deferens by prostacyclin analogues. Br. J. Pharmacol. 121: 1413-1421, 1997.
228. TANAKA, M., C. KOJIMA, M. MURAMATSU, AND H. TANABE. Binding affinities of isocarbacyclin methyl ester and its free acid to prostanoid receptors. Arzneim. Forsch. 45: 967-970, 1995.
229. TAYLOR, B. A., W. N. FRANKEL, AND R. H. REEVES. Mouse chromosome 10. Mamm. Genome 3, Suppl.: S153-S161, 1992.
230. TERRAGNO, N. A., A. TERRAGNO, J. C. MAGIFF, AND D. J. RODRIGUEZ. Synthesis of prostaglandins by the ductus arteriosus of the bovine fetus. Prostaglandins 14: 721-727, 1977.
231. 2. J. Clin. Invest. 102: 1994-2001, 1998.
232. THOMAS, J.-P., L. J. DORFLINGER, AND H. R. BEHRMAN. Mechanism of the rapid antigonadotropic action of prostaglandins in cultured luteal cells. Proc. Natl. Acad. Sci. USA 75: 1344-1348, 1978.
233. TOH, H., A. ICHIKAWA, AND S. NARUMIYA. Molecular evolution of receptors for eicosanoids. FEBS Lett. 361: 17-21, 1995.
234. UEHARA, A., P. E. GOTTSCHALL, R. R. DAHL, AND A. ARIMURA. Interleukin-1 stimulates ACTH release by an indirect action which requires endogenous corticotropin releasing factor. Endocrinology 121: 1580-1582, 1987.
235. 2 in rapidly growing rats: depressed longitudinal and radial growth and increased metaphyseal hard tissue mass. Bone 6: 79-86, 1985.
236. 2 in allergic response and parturition. Nature 390: 618-622, 1997.
237. URADE, Y., K. KITAHAMA, H. OHISHI, T. KANEKO, N. MIZUNO, AND O. HAYAISHI. Dominant expression of mRNA for prostaglandin D synthase in leptomeninges, choroid plexus, and oligodendrocytes of the adult rat brain. Proc. Natl. Acd. Sci. USA 90: 9070-9074, 1993.
238. 2 receptor is highly expressed in mouse immature thymocytes and mediates DNA fragmentation and apoptosis. J. Exp. Med. 178: 1825-1830, 1993.
239. 2 receptor from human blood platelets. J. Biol. Chem. 264: 16496-16501, 1989.
240. i2 in phospholipid vesicles. Mol. Pharmacol. 46: 808-816, 1994.
241. 3. Nature 395: 281-284, 1998.
242. VANE, J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin like drugs. Nature New Biol. 231: 232-235, 1971.
243. VASSAUX, G., D. GAILLARD, G. AILHAUD, AND R. NEGREL. Prostacyclin is a specific effector of adipose cell differentiation. J. Biol. Chem. 268: 11092-11097, 1992.
244. 1 subtype of prostaglandin E receptor. J. Biol. Chem. 268: 20175-20178, 1993.
245. WATANABE, T., A. MORIMOTO, Y. SAKATA, AND N. MURAKAMI. ACTH response induced by interleukin-1 is mediated by CRF secretion stimulated by hypothalamic PGE. Experientia 46: 481-484, 1990.
246. 2+ dependent intracellular pathway in NIH-3T3 cells. J. Biol. Chem. 269: 17619-17625, 1994.
247. WATANABE, T., Y. YATOMI, S. SUNAGA, I. MIKI, A. ISHII, A. NAKAO, M. HIGASHIHARA, Y. SEYAMA, M. OGURA, H. SAITO, K. KUROKAWA, AND T. SHIMIZU. Characterization of prostaglandin and thromboxane receptors expressed on a megakaryoblastic leukemia cell line, MEG-01s. Blood 78: 2328-2336, 1991.
248. 2-receptor agonist. Prostaglandins 46: 371-383, 1993.
249. YAMASAKI, S., A. KAWAMOTO, M. HAYASHI, M. OHYAMA, K. MACHII, M. NAKA, K. KONDO, AND N. HAMANAKA. ONO-1301, a novel non-prostanoid prostacyclin mimetic with a potent inhibitory activity against thromboxane synthase. Jpn. J. Pharmacol. 67, Suppl. I: 3-110, 1995.
250. 2. Biochem. Biophys. Res. Commun. 198: 999-1006, 1994.
251. YASUDA, H., N. SHIMA, N. NAKAGAWA, K. YAMAGUCHI, M. KINOSAKI, S. MOCHIZUKI, A. TOMOYASU, K. YANO, M. GOTO, A. MURAKAMI, E. TSUDA, T. MORINAGA, K. HIGASHIO, N. UDAGAWA, N. TAKAHASHI, AND T. SUDA. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclstogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA 95: 3597-3602, 1998.
252. 4 that mediates chemotaxis. Nature 387: 620-624, 1997.
253. YOUNG, W. S., III, E. SHEPARD, J. AMICO, L. HENNIGHAUSEN, K. U. WAGNER, M. E. LAMARCA, C. McKINNEY, AND E. I. GINNS. Deficiency in mouse oxytocin prevents milk ejection, but not fertility or parturition. J. Neuroendocrinol. 8: 847-853, 1996.
254. ZAMPRONIO, A. R., G. E. P. SOUZA, C. A. A. SILVA, F. Q. CUNHA, AND S. H. FERREIRA. Interleukin-8 induces fever by a prostaglandin-independent mechanism. Am. J. Physiol. 266 (Regulatory Integrative Comp. Physiol. 35): R1670-R1674, 1994.